(Q37566090)

21 August 2017

1 reference

title

Prescription omega-3-acid ethyl esters for the treatment of very high triglycerides (English)

1 reference

21 August 2017

1 reference

Penny M. Kris-Etherton

series ordinal

2

object named as

Penny Kris-Etherton

0 references

author name string

Richard Sadovsky

series ordinal

1

1 reference

21 August 2017

language of work or name

English

0 references

publication date

1 July 2009

1 reference

21 August 2017

published in

Postgraduate Medicine

1 reference

21 August 2017

volume

121

1 reference

21 August 2017

issue

4

1 reference

21 August 2017

page(s)

145-153

1 reference

Hypertriglyceridemia and its pharmacologic treatment among US adults

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.07.2020

Clinical overview of Omacor: a concentrated formulation of omega-3 polyunsaturated fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.07.2020

Intestinally derived lipids: metabolic regulation and consequences--an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.07.2020

Comprehensive lipid management versus aggressive low-density lipoprotein lowering to reduce cardiovascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.07.2020

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.07.2020

Translating molecular discoveries into new therapies for atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.07.2020

Rationale for prescription omega-3-acid ethyl ester therapy for hypertriglyceridemia: a primer for clinicians

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.07.2020

Hypertriglyceridemia: its etiology, effects and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.07.2020

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.07.2020

Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.07.2020

Metabolic risk during antipsychotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.07.2020

Hypertriglyceridemia as a cardiovascular risk factor

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.07.2020

The advantages of using non-HDL-C in the diagnosis and treatment of dyslipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.07.2020

Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.07.2020

Mechanisms for the hypotriglyceridemic effect of marine omega-3 fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.07.2020

Correlation of serum triglyceride and its reduction by omega-3 fatty acids with lipid transfer activity and the neutral lipid compositions of high-density and low-density lipoproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.07.2020

Differentiating prescription omega-3-acid ethyl esters (P-OM3) from dietary-supplement omega-3 fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.3810%2FPGM.2009.07.2020

21 January 2018

Identifiers

DOI

10.3810/PGM.2009.07.2020

1 reference

21 August 2017

1 reference